Cheaper Generic PrEP Now Available in the United States

Cheaper Generic PrEP Now Available in the United States

Multiple generic formulations of tenofovir disoproxil fumarate/emtricitabine—the equivalent of Truvada—are now available in the United States for HIV treatment and prevention, leading to a dramatic drop in the price of pre-exposure prophylaxis (PrEP). But the coformulation of tenofovir disoproxil fumarate (TDF) and emtricitabine was protected by patents, and the brand-name cost has been around $1,600 to $1,800 per month. Teva’s generic product hit the U.S. market in October 2020, but at about $1,455 a month, it undercut the cost of brand-name Truvada by only a couple of hundred dollars. According to drug price comparison sites, such as GoodRx.com and RxSaver.com, generic Truvada can be purchased for as little as $69 per month with discount coupons. Many people in the United States don’t pay full price for brand-name Truvada because it is covered by commercial insurance, Medicaid or Medicare.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!